R. Martin Chavez

R. Martin Chavez Appointed Chairman of Recursion's Board of Directors

Retrieved on: 
Monday, March 1, 2021

SALT LAKE CITY, March 1, 2021 /PRNewswire/ -- Recursion , a digital biology company industrializing drug discovery, today announced the appointment of R. Martin Chavez as Chairman of its Board of Directors.

Key Points: 
  • SALT LAKE CITY, March 1, 2021 /PRNewswire/ -- Recursion , a digital biology company industrializing drug discovery, today announced the appointment of R. Martin Chavez as Chairman of its Board of Directors.
  • Dr. Chavez, who joined Recursion's Board of Directors in 2020, will serve as the company's first independent Chairman.
  • "It has been such a pleasure to welcome multiple fantastic independent Board members to Recursion over the past year.
  • "I am thrilled to serve as Recursion's first independent Chairman of the Board," said Dr. Chavez.

Notable Financial and Technology Executive R. Martin Chavez Joins Sema4 Board of Directors

Retrieved on: 
Tuesday, May 19, 2020

Sema4 , a patient-centered health intelligence company, today announced the appointment of prominent Wall Street and technology executive R. Martin Chavez to its Board of Directors.

Key Points: 
  • Sema4 , a patient-centered health intelligence company, today announced the appointment of prominent Wall Street and technology executive R. Martin Chavez to its Board of Directors.
  • Mr. Chavez most recently served in several senior roles for Goldman Sachs, including Chief Information Officer, Chief Financial Officer, and global co-head of the firms Securities Division.
  • View the full release here: https://www.businesswire.com/news/home/20200519005286/en/
    Notable financial and technology executive R. Martin Chavez joins Sema4 Board of Directors (Photo: Business Wire)
    Marty is a leading thinker in harnessing advanced computer science and big data analytics to transform key industries as he successfully did in the global finance arena, said Eric Schadt , PhD, Founder and Chief Executive Officer of Sema4.
  • Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

R. Martin Chavez Joins Paige's Board of Directors

Retrieved on: 
Friday, January 10, 2020

NEW YORK, Jan. 10, 2020 /PRNewswire-PRWeb/ -- Paige, the leader in computational pathology transforming the diagnosis and treatment of cancer, welcomes Dr. R. Martin Chavez to its board of directors.

Key Points: 
  • NEW YORK, Jan. 10, 2020 /PRNewswire-PRWeb/ -- Paige, the leader in computational pathology transforming the diagnosis and treatment of cancer, welcomes Dr. R. Martin Chavez to its board of directors.
  • Chavez joins Paige's board after recently retiring from Goldman Sachs, where he served 19 years in multiple roles including CIO, CFO, and Co-Head of Securities.
  • He currently serves on the Board of Overseers of Harvard University, the Stanford Medicine Board of Fellows and the Board of Trustees of the Institute for Advanced Study.
  • Chavez joins the Paige board of directors after a stellar year of significant momentum for the Company.